Comerica Bank’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.8M | Sell |
36,125
-558
| -2% | -$27.1K | 0.01% | 1171 |
|
|
2025
Q3 | $1.75M | Sell |
36,683
-2,744
| -7% | -$111K | 0.01% | 1226 |
|
|
2025
Q2 | $1.24M | Buy |
39,427
+2,853
| +8% | +$91.4K | ﹤0.01% | 1397 |
|
|
2025
Q1 | $1.2M | Sell |
36,574
-974
| -3% | -$34.5K | 0.01% | 1394 |
|
|
2024
Q4 | $1.36M | Buy |
37,548
+15,585
| +71% | +$549K | 0.01% | 1369 |
|
|
2024
Q3 | $685K | Sell |
21,963
-655
| -3% | -$20.4K | ﹤0.01% | 1737 |
|
|
2024
Q2 | $605K | Sell |
22,618
-2,622
| -10% | -$76K | ﹤0.01% | 1755 |
|
|
2024
Q1 | $861K | Sell |
25,240
-2,380
| -9% | -$70.9K | ﹤0.01% | 1611 |
|
|
2023
Q4 | $799K | Sell |
27,620
-4
| -0% | -$106 | ﹤0.01% | 1633 |
|
|
2023
Q3 | $762K | Buy |
+27,624
| New | +$841K | ﹤0.01% | 1576 |
|
|
2022
Q4 | $1.3M | Sell |
32,528
-8,925
| -22% | -$310K | 0.01% | 1318 |
|
|
2022
Q3 | $1.41M | Sell |
41,453
-4,485
| -10% | -$146K | 0.01% | 1277 |
|
|
2022
Q2 | $1.38M | Sell |
45,938
-35
| -0.1% | -$1K | 0.01% | 1330 |
|
|
2022
Q1 | $1.36M | Sell |
45,973
-155
| -0.3% | -$4.75K | 0.01% | 1402 |
|
|
2021
Q4 | $1.37M | Sell |
46,128
-2,528
| -5% | -$76.7K | 0.01% | 1394 |
|
|
2021
Q3 | $1.45M | Sell |
48,656
-912
| -2% | -$24.5K | 0.01% | 1505 |
|
|
2021
Q2 | $1.17M | Sell |
49,568
-3,898
| -7% | -$120K | 0.01% | 1639 |
|
|
2021
Q1 | $1.68M | Sell |
53,466
-1,890
| -3% | -$52.9K | 0.01% | 1464 |
|
|
2020
Q4 | $1.66M | Buy |
55,356
+296
| +0.5% | +$6.37K | 0.01% | 1420 |
|
|
2020
Q3 | $1.11M | Sell |
55,060
-165
| -0.3% | -$3.75K | 0.01% | 1494 |
|
|
2020
Q2 | $1.3M | Buy |
55,225
+4,179
| +8% | +$92.3K | 0.01% | 1352 |
|
|
2020
Q1 | $968K | Buy |
51,046
+1,857
| +4% | +$39K | 0.01% | 1368 |
|
|
2019
Q4 | $1.15M | Sell |
49,189
-39
| -0.1% | -$947 | 0.01% | 1472 |
|
|
2019
Q3 | $1.31M | Sell |
49,228
-257
| -0.5% | -$7.62K | 0.01% | 1362 |
|
|
2019
Q2 | $1.58M | Sell |
49,485
-2,668
| -5% | -$91.4K | 0.01% | 1258 |
|
|
2019
Q1 | $2.01M | Buy |
52,153
+1,436
| +3% | +$53.4K | 0.02% | 1124 |
|
|
2018
Q4 | $1.86M | Buy |
50,717
+169
| +0.3% | +$7.27K | 0.02% | 1141 |
|
|
2018
Q3 | $2.39M | Sell |
50,548
-4,082
| -7% | -$202K | 0.02% | 1006 |
|
|
2018
Q2 | $2.92M | Buy |
54,630
+603
| +1% | +$31.2K | 0.02% | 1000 |
|
|
2018
Q1 | $2.64M | Buy |
54,027
+1,261
| +2% | +$52.6K | 0.02% | 1066 |
|
|
2017
Q4 | $2.28M | Sell |
52,766
-952
| -2% | -$37.6K | 0.02% | 1186 |
|
|
2017
Q3 | $2.2M | Buy |
53,718
+755
| +1% | +$32.7K | 0.02% | 1159 |
|
|
2017
Q2 | $2.3M | Sell |
52,963
-2,696
| -5% | -$96K | 0.02% | 1111 |
|
|
2017
Q1 | $1.85M | Buy |
55,659
+2,828
| +5% | +$75.8K | 0.01% | 1272 |
|
|
2016
Q4 | $1.33M | Buy |
52,831
+2,771
| +6% | +$61.9K | 0.01% | 1457 |
|
|
2016
Q3 | $1.19M | Buy |
50,060
+14,886
| +42% | +$337K | 0.01% | 1409 |
|
|
2016
Q2 | $815K | Buy |
35,174
+413
| +1% | +$7.33K | 0.01% | 1610 |
|
|
2016
Q1 | $567K | Buy |
34,761
+293
| +0.9% | +$3.82K | 0.01% | 1715 |
|
|
2015
Q4 | $403K | Buy |
34,468
+194
| +0.6% | +$3K | ﹤0.01% | 1786 |
|
|
2015
Q3 | $481K | Sell |
34,274
-23,552
| -41% | -$438K | ﹤0.01% | 1725 |
|
|
2015
Q2 | $982K | Buy |
+57,826
| New | +$823K | ﹤0.01% | 1776 |
|
Other funds holding SUPN
AC
NAMI
Comerica Bank's SUPN Position: Q4 2025 in Review
Comerica Bank reduced its Supernus Pharmaceuticals (SUPN) stake by 1.5% in Q4 2025, selling an estimated $27.1K and leaving 36,125 shares worth $1.8M. The position accounts for 0.01% of the portfolio, ranked #1171.
Comerica Bank first reported a position in SUPN in Q2 2015 and has held it in 41 quarters since. The position peaked at $2.92M in Q2 2018. 333 funds tracked by Wall St. Rank hold SUPN as of Q4 2025.
- Comerica Bank held 36,125 shares of Supernus Pharmaceuticals worth $1.8M as of Q4 2025.
- Comerica Bank sold 558 Supernus Pharmaceuticals shares in Q4 2025, an estimated $27.1K.
- Supernus Pharmaceuticals made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1171 holding.
- Comerica Bank first reported a position in Supernus Pharmaceuticals in Q2 2015 and has held it in 41 quarters since.
- Comerica Bank's Supernus Pharmaceuticals position peaked at $2.92M in Q2 2018.
- 333 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2025.
Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.